Skip to main content
SpringerLink
Log in

Rituximab subkutan

Mehr Lebensqualität

  • In|Fo|Pharm
  • Published:
Info Onkologie Aims and scope

Statt in einer aufwändigen Infusion kann der Anti-CD20 Antikörper Rituximab auch innerhalb weniger Minuten subkutan appliziert werden — ein Gewinn für die Patienten.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Praxisworkshop „Lebensqualität im Fokus: MabThera® sc und die Therapie des follikulären Lymphoms in der onkologischen Praxis“, Recklinghausen, 18. September 2013, Veranstalter: Roche

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Christine Vetter

Authors
  1. Christine Vetter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vetter, C. Rituximab subkutan. Info Onkol. 16, 60 (2013). https://doi.org/10.1007/s15004-013-0694-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-013-0694-9

Search

Navigation